DENAVIR

LOE ApproachingSM

penciclovir

NDATOPICALCREAM
Approved
Sep 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

DNA Polymerase Inhibitors

Pharmacologic Class:

Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Clinical Trials (1)

NCT00820534Phase 4Completed

A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers

Started Dec 2008
126 enrolled
Cold Sore